HEALTH

The Hidden Role of TMEM9B-AS1 in Muscle Health

Thu Jul 10 2025

In the world of tiny molecules, long noncoding RNAs (lncRNAs) are like secret bosses. They don't make proteins, but they control many important jobs in our cells. One of these bosses, TMEM9B-AS1, has been found to be less active in the muscles of people with type 2 diabetes and muscle loss. This is a big deal because it might be a key player in muscle health.

The Role of TMEM9B-AS1

Scientists found that when TMEM9B-AS1 is not working well, muscles make less protein. This happens because an important protein called S6 is not being activated properly. But that's not all. TMEM9B-AS1 also helps to keep the instructions for making new ribosomes stable.

Ribosomes: The Tiny Factories

Ribosomes are like tiny factories in our cells that make proteins. Without enough of them, muscles can't repair or grow properly.

Teamwork with IGF2BP1

TMEM9B-AS1 does this important job by teaming up with another molecule called IGF2BP1. Together, they make sure that the instructions for making new ribosomes are not broken down too quickly. When TMEM9B-AS1 is not working, these instructions get destroyed faster, and muscles suffer.

Future Research

This discovery shows that TMEM9B-AS1 is not just a bystander. It's a key player in muscle health, especially in people with type 2 diabetes. Understanding how it works could lead to new ways to help people keep their muscles strong and healthy.

But there's still a lot we don't know. For example, why is TMEM9B-AS1 less active in the first place? And can we find ways to boost its activity? These are big questions that scientists will need to tackle in the future.

questions

    What are the long-term effects of TMEM9B-AS1 down-regulation on overall muscle health and metabolic function beyond type 2 diabetes and sarcopenia?
    What are the potential confounding factors that could influence the down-regulation of TMEM9B-AS1 in skeletal muscle of people with type 2 diabetes?
    How does the down-regulation of TMEM9B-AS1 specifically contribute to the progression of type 2 diabetes in skeletal muscle?

actions